Docking-based 3D-QSAR modeling of the inhibitors of IMP metallo-β-lactamase

Medicinal Chemistry Research

Volumn 22, Issue 4, 2013, Pages 1730-1739

  Chen, Jiao ^a   Yu, Rong ^a   Shen, Bingzheng ^a   Xu, Yan ^a   Liu, Yifang ^a   Zheng, Heng ^a   Yao, Wenbing ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Lactam resistance; 3D QSAR; Docking; IMP metallo lactamase

Indexed keywords

BETA LACTAMASE INHIBITOR; METALLO BETA LACTAMASE; METALLO BETA LACTAMASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; BIOLOGICAL ACTIVITY; COMPARATIVE MOLECULAR FIELD ANALYSIS; COMPARATIVE MOLECULAR SIMILARITY INDICES ANALYSIS; DRUG DESIGN; HYDROGEN BOND; HYDROPHOBICITY; IC 50; MOLECULAR DOCKING; PROTEIN BINDING; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

EID: 84879687310     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-012-0172-1     Document Type: Article

References (31)

1. Ai Y, Wang S, Tang C, Sun P, Song F (2011) 3D-QSAR and docking studies on pyridopyrazinones as BRAF inhibitors. Med Chem Res 20:1298-1317
2. Ambler RP (1980) The structure of beta-lactamases. Philos Trans R Soc Lond B 289:321-331
3. Bounaga S, Galleni M, Laws AP, Page MI (2001) Cysteinyl peptide inhibitors of Bacillus cereus zinc β-lactamase. Bioorg Med Chem 9:503-510
4. Briens F, Bureau R, Rault S, Robba M (1995) Applicability of CoMFA in ecotoxicology: a critical study on chlorophenols. Ecotoxicol Environ Saf 31:37-48
5. Clark M, Cramer RD, Opdenbosch NV (1989) Validation of the general purpose Tripos 5.2 forcefield. J Comput Chem 10:982-1012
6. Concha NO, Janson CA, Rowling P, Pearson S, Cheever CA, Clarke BP, Lewis C, Galleni M, Frère JM, Payne DJ, Bateson JH, Abdel-Meguid SS (2000) Crystal structure of the IMP-1 metallo β-lactamase from Pseudomonas aeruginosa and its complex with a mercaptocarboxylate inhibitor: binding determinants of a potent, broad-spectrum inhibitor. Biochemistry 39:4288-4298
7. Cramer RD, Patterson DE, Bunce JD (1989) Recent advances in comparative molecular field analysis (CoMFA). Prog Clin Biol Res 291:161-165
8. Galleni M, Lamotte-Brasseur J, Rossolini GM, Spencer J, Dideberg O, Frere JM (2001) Standard numbering scheme for class B β-lactamases. Antimicrob Agents Chemother 45:660-663
9. Garau G, Garcia-Saez I, Bebrone C, Anne C, Mercuri P, Galleni M, Frere JM, Dideberg O (2004) Update of the standard numbering scheme for class B β-lactamases. Antimicrob Agents Chemother 48:2347-2349
10. Gasteiger J, Marsili M (1980) Iterative partial equalization of orbital electronegativity - a rapid access to atomic charges. Tetrahedron 36:3219-3228
11. 2. J Mol Graph Model 20:269-276
12. Greenlee ML, Laubet JB, Balkovec JM, Hammond ML, Hammond GG, Pompliano DL, Epstein-Toney JH (1999) Synthesis and SAR of thioester and thiol inhibitors of IMP-1 metallo-beta-lactamase. Bioorg Med Chem Lett 9:2549-2554
13. Hammond GG, Huber JL, Greenlee ML (1999) Inhibition of IMP-1 metallo-β-lactamase and sensitization of IMP-1-producing bacteria by thioseter derivatives. FEMS Microbiol Lett 179:289-296
14. Hyun KH, Lee DY, Lee BS, Kim CK (2004) Receptor-based 3D QSAR studies on PPARγ agonists using CoMFA and CoMSIA Approaches. QSAR Comb Sci 23:637-649
15. Jarrod W, Gretes M, Valerie J (2010) Cyclobutanone analogues of beta-lactams revisited: insights into conformational requirements for inhibition of serine and metallo-beta-lactamases. J Am Chem Soc 132:2558-2560
16. Ken C, Mizuyo I, Takao A, Yukiko H, Akihiro M, Toshiaki K (2008) Metallo-beta-lactamase inhibitors. US 20080090825A1
17. Klebe G (1998) Comparative molecular similarity indices analysis: CoMSIA. Perspect Drug Discov Des 12(13/14):87-104
18. Kunick C, Lauenroth K, Wieking K, Xie X, Schultz C, Gussio R, Zaharevitz D, Leost M, Meijer L, Weber A, Jørgensen FS, Lemcke T (2004) Evaluation and comparison of 3D-QSAR CoMSIA models for CDK1, CDK5, and GSK-3 inhibition by Paullones. J Med Chem 47:22-36
19. Kurosaki H, Yamaguchi Y, Higashi T, Soga K, Matsueda S, Yumoto H, Misumi S, Yamagata Y, Arakawa Y, Goto M (2005) Irreversible inhibition of metallo-beta-lactamase (IMP-1) by 3-(3-mercaptopropionylsulfanyl)propionic acid pentafluorophenyl ester. Angew Chem Int Ed Engl 44:3861-3864
20. Kurosaki H, Yamaguchi Y, Yasuzawa H, Jin W, Yamagata Y, Arakawa Y (2006) Probing, inhibition, and crystallographic characterization of metallo-beta-lactamase (IMP-1) with fluorescent agents containing dansyl and thiol groups. Chem Med Chem 1:969-972
21. Neaz MM, Pasha FA, Muddassar M, Lee SH, Sim T, Hah JM, Cho SJ (2009) Pharmacophore based 3D-QSAR study of VEGFR-2 inhibitors. Med Chem Res 18:127-142
22. Ohsuka S, Arakawa Y, Horii T, Ito H, Ohta M (1995) Effect of pH on activities of novel beta-lactamases and beta-lactamase inhibitors against these beta-lactamases. Antimicrob Agents Chemother 39:1856
23. Olsen L, Pettersson I, Hemmingsen L, Adolphe HW, Jørgensen FS (2004) Docking and scoring of metallo-β-lactamases inhibitors. J Comput Aided Mol Des 18:287-302
24. Olsen L, Jost S, Adolph HW, Pettersson I, Hemmingsene L, Jørgensen FS (2006) New leads of metallo-β-lactamase inhibitors from structure-based pharmacophore design. Bioorgan Med Chem 14:2627-2635
25. Osano E, Arakawa Y, Wacharotayankun R, Ohta M, Horii T, Ito H (1994) Molecular characterization of an enterobacterial metallo-beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob Agents Chemother 38:71-78
26. Rie N, Yuka A, Hideaki I, Koji Y, Terutaka H, Hajime M (1999) Carbapenem derivatives as potential inhibitors of various β-lactamases, including class B metallo-β-lactamases. Antimicrob Agents Chemother 43:2497-2503
27. Siemann S, Evano DP, Marrone L, Clarke AJ, Viswanatha T, Dmitrienko GI (2002) N-sulfonyl hydrazones as IMP-1 Metallo-β-lactamase. Antimicrob Agents Chemother 46:2450-2457
28. Sonawane LV, Bari SB (2011) Ligand-based in silico 3D-QSAR study of PPAR-c agonists. Med Chem Res 20:1005-1014
29. Toney JH, Hammond GG, Fitzgerald PMD, Sharma N, Balkovec JM, Rouen GP, Olson SH, Hammond ML, Greenlee ML, Gao YD (2001) Succinic acids as potent inhibitors of plasmid-borne IMP-1 metallo-β-lactamase. J Biol Chem 276:31913-31918
30. Wang R, Gao Y, Liu L, Lai L (1998) All-orientation search and all-placement search in comparative molecular field analysis. J Mol Model 4:276-283
31. Wold S, Ruhe A, Wold H, Dunn WJ (1984) The collinearity problem in linear regression: the partial least squares (PLS) approach to generalized inverses. SIAM J Sci Stat Comput 5:735-743